← Evidence map

ArticlebioRxiv : the preprint server for biology2026

SMARCAL1 is a candidate therapeutic target for ALT-positive tumors.

Angelo Taglialatela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41757119